Home ›
Trademark Categories ›
Pharmaceuticals ›
2021 ›
OR ›
ORYZA HEALTH SCIENCES
Trademark search for:
ORYZA HEALTH SCIENCES
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-08-26 — Application filed
2021-08-30 — Application filed
2021-10-12 — Application filed
2022-05-31 — Assigned to examiner
2022-06-03 — Final disposition recorded
2022-06-03 — Final disposition recorded
2022-06-03 — Final disposition recorded
2022-11-16 — Office action issued
2022-11-16 — Correspondence received in law office
2022-11-17 — Teas/email correspondence entered
2023-01-12 — Final disposition recorded
2023-01-12 — Final disposition recorded
2023-01-12 — Final disposition recorded
2023-04-12 — Application filed
2023-04-12 — Application filed
2023-07-12 — Office action issued
2023-07-12 — Correspondence received in law office
2023-07-13 — Teas/email correspondence entered
2023-08-10 — Office action issued
2023-08-10 — Office action issued
2023-08-10 — Office action issued
2023-11-09 — Application filed
2023-11-09 — Application filed
2024-02-09 — Exparte appeal received at ttab
2024-02-09 — Jurisdiction restored to examining attorney
2024-02-09 — Ex parte appeal-instituted
2024-06-11 — Notification of action denying req for recon e-mailed
2024-06-11 — Action denying req for recon e-mailed
2024-06-11 — Final disposition recorded
2024-12-12 — Jurisdiction restored to examining attorney
2025-02-07 — Notification of examiners statement e-mailed
2025-02-07 — Examiners statement - completed
2025-02-07 — Examiners statement e-mailed
2025-02-28 — Reply brief filed - check ttab files
2025-04-14 — Office action issued
2025-07-14 — Application abandoned
2025-07-14 — Exparte appeal terminated
2025-07-14 — Final status recorded
2025-07-21 — Application abandoned
Owner Information
Oryza Pharmaceuticals, Inc.
Correspondent
E. ANTHONY FIGG ROTHWELL, FIGG, ERNST & MANBECK, PC
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
